Vertex Pharmaceuticals VRTX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.99B+7.8% | $3.19B+9.5% | $3.08B+11.0% | $2.96B+12.1% | $2.77B+3.0% | ||
| $392.8M+8.2% | $466M+10.1% | $414.8M+5.7% | $407.5M+9.6% | $363M+6.0% | ||
| $2.59B+7.8% | $2.72B+9.5% | $2.66B+11.9% | $2.56B+12.5% | $2.41B+2.5% | ||
| 86.8%0.0pp | 85.4%-0.1pp | 86.5%+0.7pp | 86.3%+0.3pp | 86.9%-0.4pp | ||
| $493.7M+24.5% | $487M+29.0% | $445.1M+19.7% | $424.6M+14.1% | $396.4M+15.7% | ||
| $1.85B-13.6% | $1.98B+5.2% | $1.89B+14.2% | $1.81B-70.6% | $2.14B+38.0% | ||
| $1.14B+80.6% | $1.21B— | $1.19B+6.3% | $1.15B+133% | $630.1M-44.7% | ||
| 38.1%+15.4pp | 37.8%— | 38.6%-1.7pp | 38.8%+172pp | 22.7%-19.6pp | ||
| $1.25B+71.5% | $1.33B+17.1% | $1.3B+6.1% | $1.28B+138% | $730.4M-42.9% | ||
| $221.5M+163% | $139.9M-37.4% | $215.9M+20.8% | $250.1M+23.6% | $84.1M-53.1% | ||
| $1.03B+59.6% | $1.19B— | $1.08B+3.6% | $1.03B+129% | $646.3M-41.2% | ||
| 34.5%+11.2pp | 37.3%— | 35.2%-2.5pp | 34.8%+171pp | 23.3%-17.5pp | ||
| $4.02+61.4% | $4.64— | $4.20+4.7% | $3.99+129% | $2.49-40.9% | ||
| $1.19B+76.0% | $1.26B+6.4% | $1.24B+6.0% | $1.2B+135% | $678.5M-43.1% | ||
| 40%+15.5pp | 39.5%-1.2pp | 40.3%-1.9pp | 40.6%+171pp | 24.5%-19.8pp | ||
| $1.14B+80.6% | $1.21B+5.8% | $1.19B+6.3% | $1.15B+133% | $630.1M-44.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Vertex Pharmaceuticals's revenue?
- Vertex Pharmaceuticals (VRTX) generated $12.2B in revenue over the trailing twelve months, up 10.1% year over year.
- Is Vertex Pharmaceuticals profitable?
- Vertex Pharmaceuticals reported $4.3B in net income over the trailing twelve months, a 35.5% net margin.
- What are Vertex Pharmaceuticals's profit margins?
- Gross margin is 86.2% and operating margin is 38.3%, with a 35.5% net margin.
- What is Vertex Pharmaceuticals's earnings per share?
- Vertex Pharmaceuticals's diluted EPS over the trailing twelve months is $16.85.
- Where does Vertex Pharmaceuticals's income statement data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
